Rhumbline Advisers cut its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 626,055 shares of the company's stock after selling 20,859 shares during the period. Rhumbline Advisers owned about 0.26% of Cardinal Health worth $74,043,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Cardinal Health by 35.2% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after acquiring an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp grew its holdings in shares of Cardinal Health by 1.5% in the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock valued at $28,435,000 after acquiring an additional 3,576 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after acquiring an additional 42,082 shares in the last quarter. Consolidated Planning Corp grew its holdings in shares of Cardinal Health by 40.0% in the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock valued at $1,056,000 after acquiring an additional 2,552 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Cardinal Health by 2.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company's stock valued at $162,976,000 after acquiring an additional 33,388 shares in the last quarter. 87.17% of the stock is owned by institutional investors.
Cardinal Health Stock Up 0.3 %
Shares of CAH stock traded up $0.38 on Wednesday, reaching $126.63. The company's stock had a trading volume of 2,290,710 shares, compared to its average volume of 2,351,541. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84. The company has a market capitalization of $30.59 billion, a P/E ratio of 23.63, a PEG ratio of 1.48 and a beta of 0.63. The stock's 50 day simple moving average is $123.25 and its 200-day simple moving average is $116.81.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. Cardinal Health's payout ratio is 37.69%.
Wall Street Analyst Weigh In
Several brokerages have weighed in on CAH. Mizuho began coverage on Cardinal Health in a report on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price objective for the company. Deutsche Bank Aktiengesellschaft increased their price objective on Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a report on Monday, November 4th. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $132.00 to $145.00 in a report on Monday, January 6th. UBS Group increased their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a report on Monday, November 4th. Finally, Barclays increased their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $136.87.
View Our Latest Report on CAH
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
